Skip to main content
HIMS
NYSE Life Sciences

Novo Nordisk Renews GLP-1 Partnership with Hims & Hers, Drops Patent Suit

Tom Rudovsky · Reported by Wiseek News
More coverage: Household Product Stocks · Consumer
Sentiment info
Positive
Importance info
9
Price
$26.02
Mkt Cap
$5.899B
52W Low
$13.74
52W High
$70.43
52W Position info
89% above low
Off High info
63% below high
Rel. Volume info
3.8× avg
Market data snapshot near publication time

HIMS sits 89% above its 52-week low of $13.74 on elevated volume (3.8× avg).

Summary

Hims & Hers Health has officially renewed its distribution agreement with Novo Nordisk to provide FDA-approved GLP-1 drugs like Ozempic and Wegovy. This significant development is further bolstered by Novo Nordisk dropping its patent lawsuit against Hims & Hers, removing a major legal and financial overhang. This news confirms the 'nearing a deal' reported on March 9th and solidifies Hims & Hers' position in the lucrative GLP-1 market, following earlier reports of its pharmacy partner resuming compounded GLP-1 sales. The resolution of the lawsuit and the confirmed partnership are highly material positive catalysts, de-risking the company and opening substantial growth avenues. Investors will now closely monitor the operational execution and financial contributions from this expanded GLP-1 offering.

At the time of this announcement, HIMS was trading at $26.02 on NYSE in the Life Sciences sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $13.74 to $70.43. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

HIMS - Latest Insights

HIMS
Nov 11, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $15.13 info
Change: -$3.87 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 1:54 PM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $18.85
Real-time Price: $15.13 info
Change: -$3.71 (-20%) info
Market Cap: $3.422B info
HIMS
Nov 10, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $22.16
Real-time Price: $15.13 info
Change: -$7.03 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 5:52 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.33
Real-time Price: $15.13 info
Change: -$7.20 (-32%) info
Market Cap: $3.422B info
HIMS
Nov 09, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $23.39
Real-time Price: $15.13 info
Change: -$8.26 (-35%) info
Market Cap: $3.422B info